BRIEF

on CompuGroup Medical SE & Co. KGaA (isin : DE000A288904)

CompuGroup Medical Finalizes Strategic Partnership with CVC

CompuGroup Medical SE & Co. KGaA has secured final regulatory approval for a voluntary public takeover offer. CVC Capital Partners, through Caesar BidCo GmbH, will acquire a 23.11% minority stake. The Gotthardt family will retain a 50.12% majority. The takeover, concluding within eight banking days, enables CVC and CompuGroup to foster innovation in the healthcare sector globally.

The offer accepted 4,387,680 shares, equivalent to 8.17% of the company's capital. An additional 14.94% was acquired outside the offer. With this strategic alliance, CompuGroup aims to enhance its long-term growth and innovation strategies, benefiting patients and healthcare professionals worldwide.

Following the acquisition, CVC plans a delisting offer with no expected increase in the tender offer price. Shareholders will receive €22.00 per share. Further delisting details are available on their website.

R. H.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all CompuGroup Medical SE & Co. KGaA news